Oxipurinol: Alloxanthine, Oxyprim™, oxypurinol

Drugs in R and D

Volumn 5, Issue 3, 2004, Pages 171-175

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CALCIUM ION; OXIPURINOL; XANTHINE OXIDASE INHIBITOR;

AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ERUPTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG RESPONSE; FATIGUE; FEVER; GOUT; HEADACHE; HEART MUSCLE CONTRACTILITY; HUMAN; HYPERURICEMIA; NAUSEA; NEPHROTIC SYNDROME; OXYGEN CONSUMPTION; PATENT; PRIORITY JOURNAL; SINGLE DRUG DOSE; VOMITING;

DRUGS, INVESTIGATIONAL; ENZYME INHIBITORS; HEART FAILURE, CONGESTIVE; HUMANS; OXYPURINOL;

EID: 2942722379     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200405030-00008     Document Type: Article

References (5)

1. Cardiome Pharma Corporation. Cardiome reports oxypurinol clinical trial results. Media Release: 22 Sep 2003. Available from URL: http://www.cardiome.com
2. Cardiome Pharma Corporation. Cardiome obtains additional oxypurinol patent. Media Release: 17 Jul 2003. Available from URL: http://www.cardiome.com
3. Walter-Sack I, de Vries JX, Kutschker C. Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individuals. European Journal of Clinical Pharmacology 49: 215-20, No. 3, 1995
4. O'Duffy JD. Oxipurinol therapy in allopurinol-sensitive patients. Arthritis and Rheumatism 36 (Suppl.): 159, Sep 1993
5. Walter-Sack I, de Vries JX, Ernst B. Uric acid lowering effect of oxipurinol sodium in hyperuricemic patients - therapeutic equivalence to allopurinol. Journal of Rheumatology 23: 498-501, No. 3, Mar 1996